Rare diseases
Investigational molecules
Locations
Ul. Wladyslawa Pytlasinskiego 10/12/14, 00-777 Warsaw, Poland
Dystrogen Therapeutics Technology Polska Sp. z o.o. is focused on clinical research in Duchenne Muscular Dystrophy, with interest in the progression of muscle weakness, loss of motor function, and disease-related impairment across different stages of the condition.
The sponsor’s research activity is centered on patient groups with both ambulatory and non-ambulatory disease profiles, reflecting attention to functional status in a severe inherited muscular disorder.
Dystrogen Therapeutics Technology Polska Sp. z o.o. runs clinical trials in conditions such as Duchenne muscular dystrophy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
